Data gathered: February 1
AI Stock Analysis - MDxHealth SA (MDXH)
Analysis generated May 22, 2024. Powered by Chat GPT.
MDxHealth SA is a molecular diagnostic company specializing in the development and commercialization of advanced epigenetic assays and service laboratories for cancer assessment and personalized medical management. Headquartered in Belgium, the company has a growing presence in various international markets, offering innovative solutions for prostate and other urologic cancers. The company's primary products such as SelectMDx and ConfirmMDx are pivotal in aiding early and accurate cancer detection, thus playing a crucial role in the healthcare industry.
Stock Alerts - MDxHealth SA (MDXH)
 |
MDxHealth SA | January 27 Price is down by -5% in the last 24h. |
|
MDxHealth SA | January 13 Price is up by 6.6% in the last 24h. |
|
MDxHealth SA | January 10 Price is down by -5.1% in the last 24h. |
|
MDxHealth SA | January 7 Price is down by -6.4% in the last 24h. |
Alternative Data for MDxHealth SA
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,833 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 234 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,388 | Sign up | Sign up | Sign up |
| Twitter Mentions | 5 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 34 | Sign up | Sign up | Sign up |
| Linkedin Employees | 262 | Sign up | Sign up | Sign up |
About MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
| Price | $1.91 |
| Target Price | Sign up |
| Volume | 76,700 |
| Market Cap | $95M |
| Year Range | $1.57 - $3.42 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Health Care Services |
In the news
 |
MDxHealth SA (NASDAQ:MDXH) Short Interest UpdateJanuary 31 - ETF Daily News |
 |
Reviewing Biodesix (NASDAQ:BDSX) & MDxHealth (NASDAQ:MDXH)December 24 - ETF Daily News |
Bladder Cancer Diagnostics Market Research 2024: Forecasts to 2034 by Test Type, Stage, Cancer Type, and End-UserJanuary 29 - GlobeNewswire |
|
 |
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue GuidanceJanuary 13 - Investing.com |
 |
Critical Survey: MDxHealth (OTCMKTS:MXDHF) and SES (OTCMKTS:SGBAF)January 4 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 23M | 9M | 14M | -11M | -3.7M | -0.400 |
| Q2 '24 | 22M | 8.9M | 13M | -12M | -5.6M | -0.420 |
| Q1 '24 | 20M | 8.9M | 11M | -8.5M | -4.7M | -0.310 |
| Q4 '23 | 19M | 6.7M | 13M | -11M | -5M | -0.390 |
| Q3 '23 | 19M | 6.8M | 13M | -10M | -2.7M | -0.400 |
Insider Transactions View All
| MVM Partners, LLC filed to buy 45,504,584 shares at $4. February 28 '23 |
Similar companies
Read more about MDxHealth SA (MDXH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of MDxHealth SA?
The Market Cap of MDxHealth SA is $95M.
What is the current stock price of MDxHealth SA?
Currently, the price of one share of MDxHealth SA stock is $1.91.
How can I analyze the MDXH stock price chart for investment decisions?
The MDXH stock price chart above provides a comprehensive visual representation of MDxHealth SA's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling MDxHealth SA shares. Our platform offers an up-to-date MDXH stock price chart, along with technical data analysis and alternative data insights.
Does MDXH offer dividends to its shareholders?
As of our latest update, MDxHealth SA (MDXH) does not offer dividends to its shareholders. Investors interested in MDxHealth SA should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of MDxHealth SA?
Some of the similar stocks of MDxHealth SA are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.